Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of pharmaceutical drugs in China. The company offers products for various indications, such as non-small cell lung cancer, lymphoma, hepatocellular carcinoma; pancreatic, breast, ovarian, and thyroid cancer; leukemia; and other diseases, such as diabetes. Shouyao Holdings (Beijing) Co., LTD. was founded in 2016 and is headquartered in Beijing, China.